ESPE Abstracts (2015) 84 P-3-1062

ESPE2015 Poster Category 3 Hypo (26 abstracts)

Congenital Hyperinsulinaemic Hypoglycaemia of Infancy, Renal Fanconi Syndrome and Hepatopathy due to a Mutation in the hnf4a Gene

Alejandro Vargas Pieck a , María Clemente León a , Ariana Campos Martorell a , Luis Castaño González b , Gema Ariceta Iraola a & Antonio Carrascosa Lezcano a

aVall d’Hebron University Hospital, Barcelona, Spain; bCruces University Hospital, Barakaldo, País Vasco, Spain

Introduction: Congenital hyperinsulinaemic hypoglycaemia of infancy (CHHI) associates with mutations in known genes in approximately 60% of cases. CHHI and mutations in HNF4A gene are reported in 0.5–2.4% in large series. A case of CHHI with renal Fanconi syndrome (FS) and hepatopathy is presented.

Clinical description: Male newborn, gestational age: 38 weeks, weight: 4250 g +2.7 S.D., length: 55 cm +3.29 S.D., developed hypoglycaemia during the first day of life. Laboratory tests on hypoglycaemia revealed high insulin and C-peptide (6.1 mU/l and 2.7 ng/ml respectively) with low β-hydroxybutyrate (10.2 mcmol/l). Glucose perfusions up to 17 mg/kg per min were needed. After CHHI diagnosis, diazoxide (8 mg/kg per day) was started normalizing glucose needs. Reduction of diazoxide was required because of hyperglycaemias and it was stopped at 3 months of age because of glycemias up to 300 mg/dl, later treatment involved adapted diet alone. Six months old: he had failure to thrive and later presented stunting and hepatomegaly, with persistent hypertransaminasemia and glucosuria. Viral and autoimmunity tests were negative. An increase of alkaline phosphatase (800–900 IU/l), low vitamin D and phosphate (3–3.2 mg/dl) were observed. At sixteen months he presented signs of rickets and FS was diagnosed. Genetic tests: positive HNF4A heterozygous mutation (exon 2, c.187C>T). Negative ABCC8 and KCNJ11. 28 months old: he is receiving treatment for the tubulopathy and recovering satisfactorily from his height and weight deficits. No relatives are phenotypically affected.

Discussion: This mutation was first reported in 2010; it is linked to CHHI, FS and frequently, macrosomia and subsequent DM. Seven cases have been reported, only one had hypertransaminasemia and liver glycogen accumulation. No other mutations causing this phenotype have been described.

Conclusions: Mutations in HNF4A must be suspected in patients with CHHI, macrosomia and diazoxide hyperresponse. During follow-up, awareness about the possibility of associated diseases is needed, like in this exceptional case.

Article tools

My recent searches

No recent searches.